Performance of NUVB Nuvation Bio | 100.6% in 12m
Compare NUVB with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Nuvation Bio with its related Sector/Index XBI
Performance Duell NUVB vs XBI
| TimeFrame | NUVB | XBI |
|---|---|---|
| 1 Day | -2.40% | -0.94% |
| 1 Week | 2.20% | -2.69% |
| 1 Month | 9.43% | -0.01% |
| 3 Months | 84.7% | -5.33% |
| 6 Months | 153.9% | 31.03% |
| 12 Months | 100.6% | 3.19% |
| YTD | 107.0% | -2.32% |
| Rel. Perf. 1m | 0.56 | |
| Rel. Perf. 3m | 7.78 | |
| Rel. Perf. 6m | 6.49 | |
| Rel. Perf. 12m | 6.73 |
Is Nuvation Bio a good stock to buy?
Probably not. Based on ValueRay Analyses, Nuvation Bio (NYSE:NUVB) is currently (May 2024)
not a good stock to buy. It has a ValueRay Growth Rating of -4.19 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NUVB as of May 2024 is 3.55. This means that NUVB is currently overvalued and has a potential downside of 9.23% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NUVB as of May 2024 is 3.55. This means that NUVB is currently overvalued and has a potential downside of 9.23% (Sold with Premium).
Is NUVB a buy, sell or hold?
- Strong Buy: 4
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
Values above 0%: NUVB is performing better - Values below 0%: NUVB is underperforming
Compare NUVB with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.37% | 7.47% | 134.74% | 72.24% |
| US NASDAQ 100 | QQQ | 1.79% | 8.57% | 136.27% | 63.71% |
| US Dow Jones Industrial 30 | DIA | 0.47% | 5.35% | 137.81% | 79.72% |
| German DAX 40 | DBXD | -0.91% | 5.04% | 131.97% | 83.16% |
| UK FTSE 100 | ISFU | 0.92% | 3.04% | 135.98% | 87.26% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2.44% | 2.73% | 151.26% | 109.11% |
| Hongkong Hang Seng | HSI | -0.21% | -5.41% | 150.00% | 109.43% |
| Japan Nikkei 225 | EXX7 | 4.80% | 14.38% | 141.08% | 87.06% |
| India NIFTY 50 | INDA | 4.11% | 10.01% | 138.26% | 76.06% |
| Brasil Bovespa | EWZ | 4.43% | 8.34% | 152.67% | 88.07% |
NUVB Nuvation Bio vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1.60% | 8.86% | 133.58% | 62.37% |
| Consumer Discretionary | XLY | 3.15% | 8.87% | 143.60% | 79.21% |
| Consumer Staples | XLP | -0.04% | 3.65% | 140.03% | 97.03% |
| Energy | XLE | 1.63% | 11.82% | 140.24% | 76.99% |
| Financial | XLF | 0.35% | 5.01% | 129.30% | 67.15% |
| Health Care | XLV | 0.65% | 6.06% | 139.93% | 90.21% |
| Industrial | XLI | 0.85% | 7.17% | 130.41% | 70.86% |
| Materials | XLB | 0.23% | 7.29% | 133.76% | 80.61% |
| Real Estate | XLRE | 0.09% | 7.90% | 141.09% | 95.04% |
| Technology | XLK | 1.90% | 9.37% | 138.30% | 63.35% |
| Utilities | XLU | -1.45% | -1.58% | 132.21% | 93.82% |
| Aerospace & Defense | XAR | 1.88% | 3.12% | 137.60% | 73.65% |
| Biotech | XBI | 4.89% | 9.44% | 122.88% | 97.43% |
| Homebuilder | XHB | 1.59% | 6.29% | 114.20% | 47.48% |
| Retail | XRT | 2.07% | 5.95% | 127.90% | 76.41% |
Does Nuvation Bio outperform its market, is NUVB a Sector Leader?
Yes, over the last 12 months Nuvation Bio (NUVB) made 100.62%, while its related Sector, the SPDR S&P Biotech (XBI) made 3.19%.
Over the last 3 months NUVB made 84.66%, while XBI made -5.33%.
Yes, over the last 12 months Nuvation Bio (NUVB) made 100.62%, while its related Sector, the SPDR S&P Biotech (XBI) made 3.19%.
Over the last 3 months NUVB made 84.66%, while XBI made -5.33%.
| Period | NUVB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 9.43% | -0.01% | 1.96% |
| 3 Months | 84.66% | -5.33% | 4.29% |
| 12 Months | 100.62% | 3.19% | 28.38% |